4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514247, 514256, A61K 31505

Patent

active

060403101

ABSTRACT:
A method of treating conditions associated with neuropeptide Y which comprises administering a compound of the formula ##STR1## to a mammalian subject in need of such treatment.

REFERENCES:
patent: 5403843 (1995-04-01), Akimoto et al.
patent: 5576337 (1996-11-01), Bruns et al.
patent: 5602024 (1997-02-01), Gerald et al.
S. Ordzhonikidze All-Union Research Institute for Pharmaceutical Chemistry (VNIKhFI), Moscow. Translated from Khimiko-farmatsevticheskii Zhurnal, vol. 22, No. 2, pp. 185-191, Feb., 1988.
S. Ordzhonikidze All-Union Scientific-Research Institute for Pharmaceutical Chemistry, Moscow. Translated from Khimiko-farmatsevticheskii Zhurnal, vol. 7, No. 3, pp. 19-24, Mar., 1973.
S. Ordzhonikidze All-Union Scientific Pharmaceutical Chemistry Research Institute, Moscow. Translated from Khimikofarmatsevticheskii Zhurnal, vol. 8, No. 1, pp. 14-17, Jan., 1974.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor an will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-730544

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.